Australian Technical Advisory Group on Immunisation

Australian Technical Advisory Group on Immunisation (ATAGI)

The Australian Technical Advisory Group on Immunisation (ATAGI) is a principal committee that provides expert advice to the Minister for Health and the Australian Government Department of Health on the medical administration of vaccines and immunisation policies in Australia. Established to ensure that the Australian immunisation schedule reflects the best scientific evidence available, ATAGI plays a critical role in public health decision-making.

History

ATAGI was established to provide technical advice on the use of vaccines in Australia, aiming to improve national immunisation coverage and to ensure the Australian Immunisation Schedule is up-to-date with the latest scientific developments. Over the years, ATAGI has been instrumental in advising on the introduction of new vaccines into the national schedule, including those for diseases such as human papillomavirus (HPV), influenza, and COVID-19.

Role and Functions

ATAGI's primary role is to advise the Minister for Health and the Australian Government Department of Health on:

• The medical administration of vaccines available in Australia, including the safety, efficacy, and effectiveness of vaccines.
• The National Immunisation Program (NIP) schedule, including recommendations for routine and catch-up vaccinations.
• Strategies to improve national immunisation coverage.
• Identification of priority areas for immunisation research.

ATAGI works closely with other key bodies such as the Therapeutic Goods Administration (TGA) and the National Centre for Immunisation Research and Surveillance (NCIRS) to ensure that its recommendations are based on the latest evidence and are in line with best practice.

Membership

ATAGI's membership comprises experts in various fields related to immunisation, including paediatrics, infectious diseases, public health, immunology, and general practice. Members are appointed by the Minister for Health, ensuring a broad range of expertise is represented.

Impact

ATAGI's advice has led to significant changes in immunisation policy and practice in Australia. Its recommendations have contributed to the introduction of new vaccines into the National Immunisation Program, changes in vaccine schedules, and the development of strategies to improve vaccine coverage. These efforts have had a profound impact on public health in Australia, leading to reductions in the incidence of vaccine-preventable diseases.

Controversies and Challenges

Like any advisory body, ATAGI has faced challenges and controversies, particularly in relation to its recommendations on vaccine use. Debates have arisen over issues such as the cost-effectiveness of certain vaccines, prioritisation of vaccine rollouts, and the balance between vaccine benefits and risks. Despite these challenges, ATAGI remains committed to providing transparent and evidence-based advice.

See Also

• Vaccination policy in Australia
• National Immunisation Program
• Therapeutic Goods Administration
• National Centre for Immunisation Research and Surveillance

External Links

• Official ATAGI Website